Clinical Trials Browser

Phase 2 × Suspended × daratumumab × Clear all

NCT06348147 2026-02-17

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Phase 2 Suspended

Multiple Myeloma